Abstract. The MB1 regulatory sequence of the myelin basic protein (MBP) gene spanning between nucleotides -14 to -50 with respect to the transcription start site is critical for cell type-specific transcription of the MBP gene, which encodes the major protein component of myelin sheath in cells derived from the central nervous system (CNS). This regulatory sequence has the ability to interact with a developmentally controlled DNA-binding protein from mouse brain that stimulates transcription of MBP promoter in an in vitro system (Haas, S., J. Gordon, and K. Khalili. 1993. Mol. Cell. Biol. 13:3103-3112). Here, we report the purification of a 39-kD protein from mouse brain tissue at the peak of myelination and MBP production that binds to the MB1 regulatory motif. Following partial amino acid sequence analysis, we have identified a complementary DNA encoding a 39-kD DNA-binding protein called pur a. Expression ofpur a cDNA in the prokaryotic and eukaryotic cells resulted in the synthesis of a protein with characteristics similar to the purified brainderived 39-kD protein in band shift competition assays. Cotransfection of the recombinant pur ~ expressor plasmid with MBP promoter construct indicated that Pur t~ stimulates transcription of the MBP promoter in oligodendrocytic cells, and that the nucleotide sequence required for binding of the 39-kD Pur c~ to DNA within the MB1 region is crucial for this activity. Moreover, transient expression of Pur a caused elevation in the level of endogenous MBP RNA in oligodendrocytic cells. Thus, Pur or, a sequence-specific DNAbinding protein upon binding to MB 1 regulatory region may play a significant role in determining the cell typespecific expression of MBP in brain.
(PNS), Schwann cells are responsible for myelin formation and expression of the MBP gene (31) . The cell type and developmental expression of myelin basic protein has been demonstrated to be regulated at the level of transcription (6, 10, 47) . Initial transgenic studies using a transgene that contained the entire MBP genomic locus including all introns and exons, as well as 4 kb of the 5' flanking sequence and 3 kb of the 3' flanking sequence revealed restricted expression of the transgene in brain with the proper developmental pattern (34) . In subsequent studies, as little as 1.3 kb of the MBP 5' flanking sequence has been shown to direct specific and developmentally regulated expression of the MBP cDNA-coding sequence (24) or a heterologous reporter gene (t2, 14, 28) . In addition, transient transfection and in vitro transcription studies have been used by several laboratories including ours to identify regulatory sequences that may participate in the restricted expression of the MBP gene (8, 9, 29, 44) . These studies have indicated that the MBP regulatory region is composed of multiple cis-acting elements, some of which stimulate transcription of the reporter gene in CNS-derived cells. The proximal element, termed MB1, spans the sequence from nucleotides -14 to -50 bp (relative to the RNA start site at +1 bp) and has been shown to direct glial cell type specific expression of a heterologous promoter. Due to its position directly upstream of the transcription start site, the MB1 element was initially thought to be involved in a direct interaction with TATA box binding protein and serve as a core promoter element for the assembly of the preinitiation complex. Sequence analysis of this region, however, indicated that the MB1 element lacks a typical TATA box, and further, in vitro transcription studies suggest that this TATA box-like sequence (TTCAAA) is not responsible for tissue-specific transcription of the MBP proximal promoter (45) . The distal regulatory element of the MBP promoter between nucleotides -93 to -209 contains multiple positive and negative regulatory elements including a binding site for the nuclear factor 1 (NF-I) family of transcription factors (21) , and differentially regulates MBP promoter activities in glial and non-glial cells. Previous studies from our laboratory indicated that the proximal MB1 regulatory region has the ability to interact with a 38--41-kD protein from crude nuclear extract derived from mouse brain tissue and stimulates transcription of the MBP promoter in an in vitro system (18) . Of particular interest was the observation that the 38-41-kD MBl-associated proteins are expressed in a tissue-specific and developmental stage-specific pattern that overlaps with the pattern of MBP transcription in the developing mouse.
In this study, we have purified a 39-kD, MBl-binding protein from mouse brain at the peak of myelination to homogeneity, identified a cDNA with the potential for encoding the 39-kD protein, and evaluated its ability to stimulate transcription of the exogenous and endogenous MBP promoter in oligodendrocytic cells.
Materials and Methods

Nuclear Extract Preparation
Mice were obtained from a commercial vendor (Jackson ImmunoResearch Labs., Inc., West Grove, PA) or from the Jefferson Cancer Institute transgenic facility (kindly provided by Dr. L. Siracusa, Jefferson Cancer Institute), and mouse brain tissue was stored at -80°C before use. Nuclear extracts were prepared from mouse brain tissue essentially by the method of Ahmed et al. (1) . Omission of the final step, concentration of the protein sample by precipitation with ammonium sulfate (0.33 g/ml), was found to increase the yield of subsequent chromatography.
Protein Purification
PhosphoceUulose Chromatography. Phosphocellulose slurry, 200 ml, was freshly packed in a 2.5 x 15-cm column (Bio-Rad Labs., Richmond, CA) to give ~90 ml packed bed volume and equilibrated with five volumes (~500 ml) buffer D10o containing 10 mM Hepes (pH 7.9), 1.5 mM MgC12, 100 mM KC1, 0.5 mM DTF, 0.5 mM PMSF, and 10% glycerol, before loading. Nuclear extract was diluted with buffer Do (D100 without KC1) to a final salt concentration of -<100 raM, as determined by conductivity measurement, and loaded by gravity flow. The column was washed with buffer Du~ until OD260 of the eluate reached baseline, and was eluted with a linear salt gradient of buffer D (400 ml total volume) containing 100-800 mM KC1. Fractions containing MBl-binding activity were identified by quantitative band shift assay.
Preparation of DNA Affinity Gels and Chromatography. DNA affinity supports were prepared essentially according to the method of Kadonaga and Tjian (22) . Cyanogen bromide activated sepharose (Pharmacia), 1.5 g, was swelled in 20 ml 1 mM HCI and washed with 300 ml 1 mM HC1 on a sintered glass funnel. The gel was immediately resuspended in 7.5 ml coupling buffer (0.1 M Na-phosphate, pH 8.0; 0.5 M NaC1) containing the DNA ligands and incubated overnight at room temperature with gentle rocking. Single-stranded oligodeoxynucleotides were purified by preparative gel electrophoresis before coupling. Following coupling, excess reactive groups in the gel were blocked by incubation of the gel in 1.0 M ethanolamine (pH 8.3) for 6 h at room temperature with gentle rocking. Uncoupled DNA was removed from the gel by washing with three cycles of buffer E1 containing 0.1 M HOAc (pH 4.0) and 0.5 M NaCI, and buffer E2 containing 0.1 M Na-phosphate (pH 8.3) and 0.5 M NaC1. The coupling efficiency was monitored by incorporation of radioactivity into the gel, and was typically 10-30% for double-stranded DNA and 1-3% for singlestranded DNA.
DNA affinity gels were packed in a 1.5 × 5-cm column (Bio Rad) resuiting in a packed bed volume of 4-5 ml. DNA affinity columns were washed with two cycles of buffer E1 and E2 before each use, then equilibrated with 10 bed volumes (~50 ml) of buffer Xls{} containing 12 mM Hepes (pH 7.9), 5 mM MgCI2, 150 mM KC1, 0.5 mM DTT, and 10% glycerol before loading. Protein samples were diluted with buffer X0 (X150 without KCI) to a final salt concentration of -<150 mM, as determined by conductivity measurement, and loaded by gravity flow. The column was washed with excessive (at least 40 ml) buffer X150 until the OD260 of the cluate reached baseline, and proteins were eluted by washing the column sequentially with 20 ml buffer Xs00 (X150 except containing 0.5 M KCI) then 20 ml buffer X1000 (X150 except containing 1.0 M KCI). Fractions containing MBl-binding activity were identified by quantitative band shift assay. DNA affinity gels were reused as many as 30 times with no apparent loss of their binding capacity.
For concentrating the active fractions, pooled fractions were dialyzed overnight against three changes, 50 volumes each, of a buffer containing 5 mM Hepes (pH 7.9), 10 mM NaCI, 1 mM MgCI2, and 0.5 mM DTT. Dialysis served to remove salt and glycerol from column fractions following chromatography. Samples were concentrated by centrifugation under vacuum (Speedvac) to 20% of their original volume. Concentration to lesser volumes resulted in increased sample viscosity and poor electrophoretic mobility of samples, presumably due to incomplete dialysis before concentration.
For amino acid analysis, second pass affinity-purified MBl-binding protein, 25 pmol as estimated by quantitative gel shift assay, was concentrated, resolved on SDS-10% PAGE, and transferred to polyvinylidine difluoride (PVDF) membrane (Immobilon-P; Millipore Corp., Bedford, MA) in a buffer containing 25 mM Tris (pH 7.8), 192 mM glycine and 15% methanol according to the manufacturer's instructions. Following transfer, the blot was stained for 15 min in 45% methanol/10% HOAc/0.1% Coomassie brilliant blue, and destained twice, 10 min each, in 45 % methanol/7% HOAc. Bands corresponding to the 37-and 39-kD proteins were excised from the blot, washed five times in HPLC-grade water (1 ml per wash) with extensive vortexing, and dried completely under vacuum (Speedvac). Samples were sent to Dr. W. Lane (Harvard Microchem, Cambridge, MA) for quantitation by amino acid analysis. Amino acid sequencing of the 39-kD MBl-binding protein was done according to the procedure described previously (20) .
Quantitative Band Shift Assay
Band shift assays were performed essentially as previously described (18) except that poly dI-dC was omitted to obtain maximal binding. Specific activity of the single-stranded MB1 end-labeled probe was determined by precipitation with trichloroacetic acid (2) and was generally 0.5-2.0 × 10 ~ cpm/txg). Complexes were detected by autoradiography of the dried gels, and the bands were excised from the gels and quantitated by liquid scintillation counting. The amount of protein present in each band was calculated based on the assumption of 1:1 stoichiometry of protein/DNA in the complex.
binding protein-Pur a fusion protein according to the procedure described previously (18) , and the complexes were analyzed on a native 9% PAGE.
Eukaryotic Expression of pur a
Pur a cDNA (1.14-kb EcoRI fragment) was placed downstream of the CMV promoter in the pcDNA3 expression vector (Stratagene Inc., La Jolla, CA). For put cL expression in eukaryotic cells, 30 I~g of the plasmid DNA was introduced into the N20.1, an oligodendrocytic cell line conditionally immortalized with a retroviral vector bearing a thermolabile SV-40 T-antigen (46) . This cell line expresses MBP and PLP messages in addition to the early oligodendrocyte marker 2',3'-cyclic nucleotide 3'-phosphodiesterase mRNA. 48 h after transfection, cells were harvested and nuclear proteins were prepared and used in band shift and competition experiments by the procedure described previously (18) .
Site-directed Mutagenesis
The DNA fragment encompassing nucleotide -86 relative to the transcription start site to +21 bp downstream of the transcription initiation site of mouse MBP that was cloned in the M13 phage DNA was used for site-directed mutagenesis in the MB1 region. The mutation was designed to reduce the binding of the 39-kD protein within the MB1 region (see Fig. 1 C, oligo MB1A*). The detail strategy for site-directed mutagenesis, and selection of the mutants by growing the transformed cells in uridine containing medium is described previously (2) . Once the mutants were identified, double-stranded phage DNA containing the mutations in the 39-kD binding site was isolated and transferred to the eukaryotic expression vector containing the chloramphenicol acetyl transferase (CAT) reporter gene. The integrity of the final construct was checked by direct sequencing before its utilization in transfection studies.
Transient Transfection and CAT Assay
Transfections were performed by the calcium phosphate precipitation methods (15) using the previously characterized oligodendrocytic cells N20.1 (46) . The salient feature of these cells is in their ability to produce MBP. After transfection, cells were maintained at 39°C to suppress expression of SV-40 T-antigen, and after 3 h, cells were harvested and CAT assay was carried out by the method described previously (13) .
Northern Blot Analysis
Total RNA from pCMV-pur ~ transfected cells was prepared by hot phenol method (2), and after DNase I digestion to remove the endogenous DNAs in the samples, equal amounts of total RNAs (20 p,g) from various samples were analyzed by Northern blot procedure (2) using cDNAs from mouse MBP (gift of Dr. Jeffrey Green, Frederick Research & Development Center, Frederick, MD) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as probes.
Results
Nuclear Proteins from Mouse Brain Recognize Single-stranded MB I DNA
Results from our previous studies have led to the identification of a nuclear protein from mouse brain that, upon interaction with the MB1 regulatory sequence of MBP, stimulates transcription of MBP promoter in an in vitro system (18) . To better understand the requirements for interaction of the MBl-binding protein to its target DNAs, mouse brain nuclear extract was probed with both doubleand single-stranded MB1 oligonucleotides in a band-shift assay. As shown in Fig. 1 , a major B-complex was detected with the double-stranded MB1 probe (A and B, lane 1). As described earlier, two other minor bands, A and C, were detected upon prolonged exposure of the autoradiogram. The single-stranded noncoding MB1 probe bound to the nuclear proteins and formed complexes with similar electrophoretic mobilities as A, B, and C ( Fig. 1 A, 
lane 2).
The coding strand of the MB1 showed an intermediate binding ability to the nuclear proteins ( Fig. 1 B, lane 2) . Competition analysis demonstrated that the participant nuclear proteins bound more tightly to the single-stranded than to the double-stranded MB1 element, since the single-stranded DNA-protein complexes could be effectively competed with homologous single-stranded DNAs, but not as efficiently with double-stranded MB1 DNA (Fig. 1 A, compare lanes 3 and 4 with 7 and 8 and B, compare lanes 3 and 4 with 5 and 6). Addition of single-stranded competitor that was complementary to the probe DNA resulted in reconstitution of double-stranded probe DNA and abolishment of the complexes (Fig. 1 A, lanes 5 and 6  and B, lanes 7 and 8) . Binding of the nuclear proteins to the noncoding strand of the MB1 element is in a sequencespecific manner, since the activity could be competed with homologous noncoding MB1 DNA, but not with an unrelated, single-stranded oligonucleotide (Fig. 1 A, compare lanes 7 and 8 with 9 and 10). Conversely, binding to the coding strand appeared nonspecific, since equivalent competition was observed with the homologous coding strand DNA and an unrelated competitor ( Fig. 1 B, compare lanes 5 and 6 with 9 and 10).
In spite of their similar electrophoretic mobilities in the band-shift assay (shown in Fig, 1 , A and B, lanes 1 and 2), one could argue that the single-stranded and doublestranded MBl-binding proteins may not be identical. However, further competition studies indicated that the formation of the A, B, and C complex requires the same sequence specificity for the single-stranded DNA as was previously described for the developmentally regulated nuclear proteins in an assay using double-stranded MB1 probe DNA (18) , supporting the notion that the participant single-and double-stranded proteins are identical. As shown in Fig. 1 D, the three complexes binding to the MB1 noncoding strand (Fig. 1 C, bottom strand) can be efficiently competed with noncoding strands from MB1, MBIA, less efficiently with MBIA*, but not with MB1E competitors. These observations demonstrate that the binding of the nuclear proteins to MB1 DNA is sequence specific, and has the target nucleotides within the MBIA oligonucleotide and that binding can be affected, at least partially, by three point mutations present in the MB1A*.
Purification of the Brain-derived MB l-binding Protein
The purification procedure for the MBl-associated proteins compromised a combination of phosphocellulose and DNA affinity chromatography. For preparation of the starting material, brains were collected from mice aged 18-60 d and protein extracts were prepared by the procedure described previously (1). Nuclear proteins (5 mg/ml bed volume) were applied to phosphocellulose resin in 50 mM KC1, and the column was eluted by a linear gradient of 100-700 mM KC1. Throughout the fractionation procedure, the activity was followed by using quantitative bandshift assay with MB1 single-stranded noncoding MB1 probe. The peak of the specific DNA-binding activity that assembled in the B-complex was eluted at 350-500 mM KCI (Fig. 2 A, lanes 13-18) . This chromatographic step resulted in fourfold purification of the MBl-associated complex (shown in Table I ), and separation of these proteins from other DNA-binding activities present in the extract. In addition to the fourfold enhancement of specific activity, phosphocellulose chromatography also removed lipids and fine particles from the extract. Purification of the MBl-associated proteins to homogeneity was performed using D N A affinity chromatography. Toward this end, an oligonucleotide corresponding to the noncoding strand of the MB1 was covalently linked to sepharose beads. The active protein fractions from phosphocellulose were pooled and applied to the affinity column, and eluted with buffer containing 0.15, 0.5, and 1.0 M KC1. All three complexes, A, B, and C, were eluted in the 0.5 M KC1 wash, however, a small amount of the slowest migrating complex (C-complex) was retained at 0.5 M KCI and eluted at 1.0 M KC1 (Fig. 2 B) . Two rounds of affinity chromatography led to 210-fold purification of the phosphocellulose fraction and 842-fold purification relative to nuclear extract (Table  I) . Through this procedure, 1,094 pmol (~44 txg) of purified MBl-binding protein was obtained that corresponds to a 9% total yield (Table I) (Fig. 2 C) .
For amino acid analysis, the more abundant protein, the 39-kD species, was digested with trypsin and the cleavage products were isolated by HPLC. Two peptides were sequenced and the results indicated a perfect match with predicted amino acid sequence of human p u r a gene (Fig.  3) . The Pur c~ is a sequence-specific single-stranded D N Abinding protein that has a high affinity for the purine-rich motif (GGN)n (3, 4) . The p u r c~ sequence predicts a protein of 322 amino acids in size, which is in good agreement with the 39-kD apparent molecular mass of the MBl-binding protein, indicating that the purified 39-kD MBl-binding protein is likely the mouse homologue of human Pur a. More recently, sequence analysis of mouse Pur c~ protein indicated extraordinary high sequence conservation between mouse and human p u r ce genes (27) . In fact, only two amino acid alterations between the human protein Phosphocellulose chromatography was performed as described in the text, with the sample loaded in a buffer containing 100 mM KC1 and eluted with a linear salt gradient of the same buffer containing 100-800 mM KC1. Fractions (1-1xl aliquots) were analyzed by band shift assay using endlabeled single-stranded noncoding strand MB1 DNA (1-5 x 105 cpm) as a probe. An outline of the chromatographic procedure and the corresponding fraction numbers are shown above the gel. The letters, A, B, and C, indicate the complexes corresponding to the developmentally regulated MBl-binding protein MEF-1 (18) , which appear to coelute as a broad peak between 350-500 mM KC1. Faster migrating complexes are also seen, which elute at 200-300 mM KC1. (B) Purification of MBl-binding protein by DNA affinity chromatography. DNA affinity chromatography was performed as described in the text, with pooled fractions from the phosphocellulose column loaded onto the MB1 (singlestranded, noncoding) affinity column in a buffer containing 150 mM KC1. The column was eluted with a step gradient of 0.5 M and 1.0 M KC1 in the same buffer. Fractions (1-1xl aliquots) were analyzed by band shift assay, using end-labeled single-stranded noncoding strand MB1 DNA (1-5 x 105 cpm) as probe. An outline of the chromatographic procedure is shown above the gel, and the corresponding fraction numbers are shown below. The letters, A, B, and C, indicate the complexes corresponding to the developmentally regulated MBl-binding protein, MEF-1 (18) , which appear to coelute with 0.5 M KCI. The complex with the slowest mobility seems to have a higher affinity for the column than the others, with a portion of this protein eluting only at the highest salt concentrations (1.0 M). (C) SDS-PAGE analysis of the purified fractions. Nuclear extract, 20 Ixg (lane 1), phosphocellulose fraction, 7 Ixg (lane 2) and two times affinity purified and the mouse protein (321 amino acids) were identified. The structural organization of P u r e t revealed three repeats of a 23-amino acid motif (class I) separated by two repeats of a 26-amino acid motif (class II). As shown in Fig. 3 , the cleavage products of the MBl-associated 39-kD protein exhibited perfect identity to the regions from class I and class II.
Binding o f P u r ~ to M B 1 Regulatory M o t i f
To evaluate the ability of Purct to bind to the MB1 sequence, the protein was produced in prokaryotic cells using the pMAL-cR1 expression vector that permits synthesis of the protein as a fusion to maltose-binding protein.
The binding ability of the Pur et fusion protein was investigated by band shift assay utilizing single-and doublestranded MB1 oligonucleotide probes. As shown in Fig. 4 A, Pur a showed strong binding activity to the noncoding strand of MB1 and exhibited a substantially reduced affinity to the coding strand and the double-stranded MB1 region (Fig. 4 A, compare lane 1 with lanes 3 and 4) . The sequence specificity of this interaction was determined by competition analysis with unlabeled oligonucleotides derived from various regions of the noncoding strand of MB1. Results from these studies indicated that the unlabeled competitor corresponding to MB1A effectively blocked association of Pur et with the probe (Fig. 4 B,  lanes 1-3) . Under similar conditions, unrelated singlestranded competitor exhibited no inhibitory action on the assembly of MB1/Pur a complex (Fig. 4 B, lanes 4 and 5) . These data demonstrate that prokaryotically produced Purct binds to the noncoding strand of the MB1 element in a sequence-specific manner.
Next, the DNA-binding activity of the cloned pur a gene product that is expressed by a eukaryotic vector in oligodendrocytic cells was examined by band shift assay. In this study, N20.1 oligodendrocytic cells were transfected with a recombinant pur a expression plasmid, pCMV-pur a, and after 48 h nuclear extracts were prepared and used in the binding assays containing single-or double-stranded MB1 D N A probes. Results shown in Fig. 5 A indicated that the eukaryotically produced Pur a prefers the noncoding strand of MB1 rather than the coding strand and the double-stranded DNAs. * One unit of bonding activity is defined as the amount of protein that will bind one pmol of radiolabeled oligonucleotide in the quantitative band shift assay. *Total protein on the basis of Bradford assay. ~Total protein is estimated by SDS-PAGE and silver staining, by comparison with known quantities of marker proteins.
specificity to that observed for the 39-kD protein shown in Fig. 1 . Of note is that our binding results indicate that nucleotides at juxtaposition of G G C of the MB1 play an important role in binding of Pur c~ to D N A since alterations of these nucleotides in the MB1A* decrease Pur c~ binding to MB1 sequence. Thus, based on the molecular mass of the purified protein, amino acid data, and the requirements for binding to the DNA, we concluded that the 39-kD MBl-binding protein is closely related to the cloned pur a gene product.
Fur a Stimulates Transcription of the M B P Gene in Oligodendrocytes
The capacity of the 39-kD Pur a to modulate transcription of the MBP gene was evaluated by cotransient transfection of N20.1 oligodendrocytes with the reporter p86-CAT and pCMV-pur a. The p86-CAT contains 86 bp upstream of the MBP transcription start site to +21 bp, downstream cloned at 5' position of the reporter C A T gene. As shown in Fig. 6 A, the basal transcriptional activity of the p86-C A T was increased in cells expressing moderate levels of Pur ct (compare lane 1 to lanes 2 and 3). At higher levels, however, Pur a showed adverse effect, most likely due to the previously described squelching effect. Inclusion of the expresser plasmid containing pur a in the antisense orientation showed no significant effect on MBP gene transcription (Fig. 6 A, lanes 6-9) . The activation of MBP promoter by Pur a, requires the intact binding site for the 39-kD protein in the MB1A region, since alteration of 5'-GCCT-GTC-3' to 5 ' -G C T C G A C -3 ' as shown in MB1A* in the reporter p86mut-CAT results in the loss of its responsiveness to Fur ~ (Fig. 6 B) . Again, antisense pur a showed no detectable effect on the transcriptional activity of the mutant promoter (Fig. 6 B, lanes 6-9) . As shown in Fig. 6 C, optimum concentration of Pur a increases transcription of the MBP promoter and that this induction requires intact Pur c~ binding site within the MB1A promoter element. The effect of Pur c~ on expression of the endogenous MBP gene was assessed by Northern blot analysis of R N A derived from N20.1 cells and cells transfected with the pur a expresser plasmid. As shown in Fig. 7 , transient expression of pur a in this oligodendrocytic cell line resulted in elevated levels of MBP R N A in the cells (Fig. 7 A) . Under similar conditions, the level of control G A P D H R N A remained constant (Fig. 7 B) and served as the baseline for the quantitative analysis shown in Fig. 7 C. Thus, the effect of Put a on MBP promoter activity is not limited to exogenously and transiently expressed messages. Rather by affecting endogenous MBP promoter activity, Put a appears to increase transcription of MBP gene in oligodendrocytes.
D i s c u s s i o n
The myelin sheath is a specialized plasma membrane structure generated by the myelin-forming cells, oligodendrocytes in the central nervous system, and Schwann cells in the peripheral nervous system. Oligodendrocytes are small cells with many processes that in white matter of the brain participate in myelination and in gray matter surround the cell bodies of neurons. A single oligodendrocyte forms myelin sheath around many axons by wrapping its plasma membrane around the axons. The initiation and maintenance of myelin sheath formation follows a complex regulatory program that is tightly controlled during brain development. -7) , and 50 and 100 development contains multiple cis-acting elements that are responsible for its unique pattern of expression. It is postulated that similar to the other eukaryotic genes, interplay between the cis-acting elements of MBP genome and the regulatory proteins that are produced in the oligodendrocytes balances the level of transcription of MBP during myelinogenesis. It is also conceivable to speculate that the tight regulation of the MBP gene transcription is mediated by a combination of positive and negative regulatory mechanisms. In an earlier effort to identify the regulatory proteins that mediate developmental expression of MBP by binding to these regulatory sequences, we employed Southwestern blot and identified a sub-region within the MB1 proximal element of MBP called MB1A (nucleotides -1 4 to -37) that binds to 39 and 37-kD protein components in young adult brain cells (26) . Through partial purification and in vitro transcription studies, we demonstrated that the MB1A-associated protein has the ability to increase transcription of the MBP promoter (18) . Here we extended those observations and by using conventional and D N A affinity chromatography, we have purified a 39-kD DNA-binding protein that upon interaction with the specific sequences within the MB1 regulatory element up-modulates transcription of the MBP promoter in oligodendrocytes. This is an interesting observation in light of the recent discovery of a repressor protein, MyEF-2, which by binding to the MB1 sequence that partially overlaps with the 39-kD protein binding site, down-regulates MBP promoter activities. Of interest, unlike the 39-kD activator protein, which is more abundant only in brain during and after the period of active myelination (18), the suppressor MyEF-2 is produced in all mouse tissues, and efficiently reduces the MBP promoter activity in nonoligodendrocytic context (17, 41) . These observations suggest that the MB1 element may function not only to stimulate brain-specific transcription, perhaps by binding to the activators such as Pur a, but could also restrict transcription of the MBP gene in other cells by interacting with repressors, including MyEF-2. Thus, programmed expression of MBP via MB1 domain may be accomplished by complex interplay of the activator(s) and suppressor(s). Perhaps it should be noted that several DNA-binding proteins including SCIP (30), CTF-NF1 (21), and thyroid hormone receptor transcription factor (11) have been shown to regulate transcription of the MBP promoter. It is also likely that interaction of Put c~ and other transcription factors become important parameters in the overall transcriptional regulation of MBP genome in oligodendrocytes. The availability of the cDNA clones for the participant activators including, Pur c~, and the suppressor, MyEF-2, (41) and SCIP should enable us to design mechanistic studies that include parallel structural and functional analysis of MBP gene expression by these regulatory proteins in oligodendrocytic cells. Examination of the effect of these regulatory proteins on transcription of other myelinng of unrelated single-stranded DNA (lanes 8-9) . The arrow shows the position of the complex and P indicates the position of the unbound probe. The sequence of the oligonucleotide competitors and the single-stranded noncoding strand of MB1 are shown in Fig. 1 C. 5) , or with equal amounts of the pCMV construct containing pur eL in the antisense orientation by the Ca-phosphate precipitation method (15) . After 48 h, extracts were prepared and CAT enzymatic activity was determined (13) . C illustrates results of these studies that examine the effect of p u t ~, the antisense pur e~, on transcription of the wild type and mutant MBP promoters. Quantitation of the CAT assays represent an average of multiple experiments. (16, 19, 37, 39, 40) . E x p e r i m e n t s are currently in progress in our laboratory to investigate the biological significance of P u r e t binding to the D N A at the level of transcription, D N A replication, and r e c o m b i n ation.
